share_log

Alnylam Pharmaceuticals | PRER14A: Preliminary revised proxy soliciting materials

Mar 18, 2019 17:24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more